• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Imaging artifacts of Onyx and PHIL on conventional CT, cone-beam CT and MRI in an animal model.动物模型中Onyx和PHIL在传统CT、锥形束CT及MRI上的成像伪影
Interv Neuroradiol. 2018 Dec;24(6):693-701. doi: 10.1177/1591019918782692. Epub 2018 Jul 4.
2
Imaging Artifacts of Nonadhesive Liquid Embolic Agents in Conventional and Cone-beam CT in a Novel in Vitro AVM Model.新型体外动静脉畸形模型中常规 CT 和锥形束 CT 下非黏附性液体栓塞剂的成像伪影。
Clin Neuroradiol. 2021 Dec;31(4):1141-1148. doi: 10.1007/s00062-021-01013-5. Epub 2021 Apr 14.
3
Imaging Artifacts of Liquid Embolic Agents on Conventional CT in an Experimental in Vitro Model.液体栓塞剂在体外实验模型常规 CT 中的影像学伪影。
AJNR Am J Neuroradiol. 2021 Jan;42(1):126-131. doi: 10.3174/ajnr.A6867. Epub 2020 Nov 19.
4
Evaluation of a novel liquid embolic agent (precipitating hydrophobic injectable liquid (PHIL)) in an animal endovascular embolization model.评价一种新型液体栓塞剂(沉淀疏水性可注射液体(PHIL))在动物血管内栓塞模型中的应用。
J Neurointerv Surg. 2018 Mar;10(3):268-274. doi: 10.1136/neurintsurg-2017-013144. Epub 2017 Jul 8.
5
Liquid Embolic Agents for Endovascular Embolization: Evaluation of an Established (Onyx) and a Novel (PHIL) Embolic Agent in an In Vitro AVM Model.用于血管内栓塞的液体栓塞剂:在体外动静脉畸形模型中对一种已确立的(Onyx)和一种新型的(PHIL)栓塞剂的评估。
AJNR Am J Neuroradiol. 2017 Jul;38(7):1377-1382. doi: 10.3174/ajnr.A5203. Epub 2017 May 18.
6
Beam hardening artifacts of liquid embolic agents: comparison between Squid and Onyx.液体栓塞剂的射束硬化伪影:Squid 和 Onyx 的比较。
J Neurointerv Surg. 2019 Jul;11(7):706-709. doi: 10.1136/neurintsurg-2018-014542. Epub 2018 Dec 19.
7
Embolization of peripheral arteriovenous malformations and fistulas with precipitating hydrophobic injectable liquid (PHIL).应用沉淀疏水性注射液体(PHIL)栓塞周围动静脉畸形和瘘管。
Radiol Med. 2021 Mar;126(3):474-483. doi: 10.1007/s11547-020-01274-z. Epub 2020 Sep 5.
8
The impact of software-based metal artifact reduction on the liquid embolic agent Onyx in cone-beam CT: a systematic in vitro and in vivo study.基于软件的金属伪影减少技术对锥形束 CT 中液体栓塞剂 Onyx 的影响:一项系统的体外和体内研究。
J Neurointerv Surg. 2022 Aug;14(8):832-836. doi: 10.1136/neurintsurg-2021-018018. Epub 2021 Aug 25.
9
Time-of-flight magnetic resonance angiography imaging of a residual arteriovenous malformation nidus after Onyx embolization for stereotactic radiosurgery planning. Technical note.用于立体定向放射外科治疗计划的Onyx栓塞术后残留动静脉畸形巢的飞行时间磁共振血管造影成像。技术说明。
Neurosurg Focus. 2009 May;26(5):E13. doi: 10.3171/2009.1.FOCUS08246.
10
Embolization of Intracranial Dural Arteriovenous Fistulas Using PHIL Liquid Embolic Agent in 26 Patients: A Multicenter Study.使用PHIL液体栓塞剂对26例颅内硬脑膜动静脉瘘进行栓塞治疗:一项多中心研究
AJNR Am J Neuroradiol. 2017 Jan;38(1):127-131. doi: 10.3174/ajnr.A5037. Epub 2016 Dec 8.

引用本文的文献

1
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.奥尼克斯液体栓塞剂:介入神经放射学应用的基础知识
J Neuroendovasc Ther. 2025;19(1). doi: 10.5797/jnet.ra.2024-0073. Epub 2024 Oct 29.
2
Obtura: A novel liquid embolic agent with post-embolization radiopacity loss, in endovascular treatment of brain arteriovenous malformations, dural arteriovenous fistulas, and tumors: CLARIDAD trial.Obtura:一种新型液体栓塞剂,在脑动静脉畸形、硬脑膜动静脉瘘和肿瘤的血管内治疗中存在栓塞后造影剂不显影现象:CLARIDAD试验
J Neurointerv Surg. 2024 Jul 16;17(5):493-499. doi: 10.1136/jnis-2023-021442.
3
Liquid Embolic Agents for Endovascular Embolization: A Review.用于血管内栓塞的液体栓塞剂:综述
Gels. 2023 May 4;9(5):378. doi: 10.3390/gels9050378.
4
Establishment of a reproducible and minimally invasive ischemic stroke model in swine.建立一种可重现且微创的猪缺血性中风模型。
JCI Insight. 2023 Apr 24;8(8):e163398. doi: 10.1172/jci.insight.163398.
5
Feasibility of Metal Artifact Reduction on CT Angiography for Planning Direct Surgery of Tentorial dAVF after Onyx Embolization.在Onyx栓塞后,利用CT血管造影减少金属伪影以规划天幕区硬脑膜动静脉瘘直接手术的可行性。
Asian J Neurosurg. 2022 Aug 25;17(2):337-341. doi: 10.1055/s-0042-1750386. eCollection 2022 Jun.
6
Visibility of liquid embolic agents in fluoroscopy: a systematic in vitro study.透视下液体栓塞剂的可视性:一项系统的体外研究。
J Neurointerv Surg. 2023 Jun;15(6):594-599. doi: 10.1136/neurintsurg-2022-018958. Epub 2022 May 4.
7
The Common but Complicated Tool: Review of Embolic Materials for the Interventional Radiologist.常用却复杂的工具:介入放射科医生的栓塞材料综述
Semin Intervent Radiol. 2021 Nov 24;38(5):535-541. doi: 10.1055/s-0041-1736658. eCollection 2021 Dec.
8
Iterative Metal Artifact Reduction (iMAR) of the Non-adhesive Liquid Embolic Agent Onyx in Computed Tomography : An Experimental Study.迭代金属伪影降低(iMAR)在计算机断层扫描中的非粘附性液体栓塞剂onyx:一项实验研究。
Clin Neuroradiol. 2022 Sep;32(3):695-703. doi: 10.1007/s00062-021-01101-6. Epub 2021 Oct 13.
9
The impact of software-based metal artifact reduction on the liquid embolic agent Onyx in cone-beam CT: a systematic in vitro and in vivo study.基于软件的金属伪影减少技术对锥形束 CT 中液体栓塞剂 Onyx 的影响:一项系统的体外和体内研究。
J Neurointerv Surg. 2022 Aug;14(8):832-836. doi: 10.1136/neurintsurg-2021-018018. Epub 2021 Aug 25.
10
Glue, Onyx, Squid or PHIL? Liquid Embolic Agents for the Embolization of Cerebral Arteriovenous Malformations and Dural Arteriovenous Fistulas.胶、玛瑙、乌贼还是 PHIL?用于栓塞脑动静脉畸形和硬脑膜动静脉瘘的液体栓塞剂。
Clin Neuroradiol. 2022 Mar;32(1):25-38. doi: 10.1007/s00062-021-01066-6. Epub 2021 Jul 29.

本文引用的文献

1
Evaluation of a novel liquid embolic agent (precipitating hydrophobic injectable liquid (PHIL)) in an animal endovascular embolization model.评价一种新型液体栓塞剂(沉淀疏水性可注射液体(PHIL))在动物血管内栓塞模型中的应用。
J Neurointerv Surg. 2018 Mar;10(3):268-274. doi: 10.1136/neurintsurg-2017-013144. Epub 2017 Jul 8.
2
Liquid Embolic Agents for Endovascular Embolization: Evaluation of an Established (Onyx) and a Novel (PHIL) Embolic Agent in an In Vitro AVM Model.用于血管内栓塞的液体栓塞剂:在体外动静脉畸形模型中对一种已确立的(Onyx)和一种新型的(PHIL)栓塞剂的评估。
AJNR Am J Neuroradiol. 2017 Jul;38(7):1377-1382. doi: 10.3174/ajnr.A5203. Epub 2017 May 18.
3
Metal artifacts in computed tomography for radiation therapy planning: dosimetric effects and impact of metal artifact reduction.用于放射治疗计划的计算机断层扫描中的金属伪影:剂量学效应及金属伪影减少的影响
Phys Med Biol. 2017 Apr 21;62(8):R49-R80. doi: 10.1088/1361-6560/aa5293. Epub 2017 Mar 21.
4
Embolization of Intracranial Dural Arteriovenous Fistulas Using PHIL Liquid Embolic Agent in 26 Patients: A Multicenter Study.使用PHIL液体栓塞剂对26例颅内硬脑膜动静脉瘘进行栓塞治疗:一项多中心研究
AJNR Am J Neuroradiol. 2017 Jan;38(1):127-131. doi: 10.3174/ajnr.A5037. Epub 2016 Dec 8.
5
Evolution of treatment and a detailed analysis of occlusion, recurrence, and clinical outcomes in an endovascular library of 260 dural arteriovenous fistulas.260 例硬脑膜动静脉瘘血管内治疗库中治疗演变及闭塞、复发和临床结果的详细分析。
J Neurosurg. 2017 Jun;126(6):1884-1893. doi: 10.3171/2016.5.JNS16331. Epub 2016 Sep 2.
6
Preclinical study on an animal model of a new non-adhesive cyanoacrylate (Purefill) for arterial embolization.新型非粘性氰基丙烯酸酯(Purefill)用于动脉栓塞的动物模型的临床前研究。
Diagn Interv Imaging. 2016 Nov;97(11):1109-1116. doi: 10.1016/j.diii.2016.05.013. Epub 2016 Jul 27.
7
A novel, non-adhesive, precipitating liquid embolic implant with intrinsic radiopacity: feasibility and safety animal study.一种新型、非粘性、具有固有放射性不透性的沉淀液体栓塞植入物:可行性和安全性动物研究。
Eur Radiol. 2017 Mar;27(3):1248-1256. doi: 10.1007/s00330-016-4463-7. Epub 2016 Jun 14.
8
Impact of iterative metal artifact reduction on diagnostic image quality in patients with dental hardware.迭代金属伪影减少对佩戴牙科硬件患者诊断图像质量的影响。
Acta Radiol. 2017 Mar;58(3):279-285. doi: 10.1177/0284185116646144. Epub 2016 Jul 20.
9
Electrochemical Effects after Transarterial Chemoembolization in Combination with Percutaneous Irreversible Electroporation: Observations in an Acute Porcine Liver Model.经动脉化疗栓塞联合经皮不可逆电穿孔后的电化学效应:急性猪肝模型观察
J Vasc Interv Radiol. 2016 Jun;27(6):913-921.e2. doi: 10.1016/j.jvir.2016.02.001. Epub 2016 Apr 18.
10
Preliminary experience with Precipitating Hydrophobic Injectable Liquid (PHIL) in treating cerebral AVMs.沉淀性疏水性可注射液体(PHIL)治疗脑动静脉畸形的初步经验。
J Neurointerv Surg. 2016 Dec;8(12):1253-1255. doi: 10.1136/neurintsurg-2015-012210. Epub 2016 Jan 27.

动物模型中Onyx和PHIL在传统CT、锥形束CT及MRI上的成像伪影

Imaging artifacts of Onyx and PHIL on conventional CT, cone-beam CT and MRI in an animal model.

作者信息

Vollherbst Dominik F, Otto Ruth, Do Thuy, Kauczor Hans U, Bendszus Martin, Sommer Christof M, Möhlenbruch Markus A

机构信息

1 Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany.

2 Clinic for Diagnostic and Interventional Radiology, Heidelberg University Hospital, Heidelberg, Germany.

出版信息

Interv Neuroradiol. 2018 Dec;24(6):693-701. doi: 10.1177/1591019918782692. Epub 2018 Jul 4.

DOI:10.1177/1591019918782692
PMID:29973083
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6259339/
Abstract

BACKGROUND AND PURPOSE

A frequently reported drawback of ethylene vinyl alcohol copolymer-based liquid embolic agents is the production of artifacts in diagnostic imaging. New embolic agents, such as Precipitating hydrophobic injectable liquid (PHIL; MicroVention, Tustin, CA, USA), are supposed to induce significantly fewer artifacts. The purpose of this study is to assess the degree of artifacts induced by the liquid embolic agents Onyx (Medtronic Neurovascular, Irvine, CA, USA) and PHIL in conventional computed tomography (CT), cone-beam CT and magnetic resonance imaging (MRI) in an experimental in vivo model.

MATERIALS AND METHODS

In 10 pigs the rete mirabile was embolized with Onyx ( n = 5) or PHIL ( n = 5). After embolization, conventional CT, cone-beam CT and MRI were performed. The degree of artifacts was graded qualitatively (five-point scale; for CT and MRI) and quantitatively (HUs of well-defined regions of interest (ROIs); for CT only).

RESULTS

Artifacts were significantly more severe for Onyx both in the qualitative (e.g. conventional CT: 2 versus 5 (medians); p = 0.008) and in the quantitative image analysis (e.g. cone-beam CT: standard deviation of a ROI near to the embolic agent cast, 94 HU versus 38 HU (medians); p = 0.008). Neither Onyx nor PHIL produced any apparent artifacts in MRI.

CONCLUSION

PHIL produces fewer artifacts than Onyx in conventional CT and cone-beam CT in an experimental in vivo model.

摘要

背景与目的

基于乙烯-乙烯醇共聚物的液体栓塞剂一个经常被报道的缺点是在诊断成像中会产生伪影。新型栓塞剂,如沉淀型疏水可注射液体(PHIL;美国加利福尼亚州图斯廷市MicroVention公司),据推测产生的伪影要少得多。本研究的目的是在实验性体内模型中评估液体栓塞剂Onyx(美国美敦力神经血管公司,加利福尼亚州欧文市)和PHIL在传统计算机断层扫描(CT)、锥束CT和磁共振成像(MRI)中所诱发的伪影程度。

材料与方法

对10头猪的奇网进行栓塞,其中5头用Onyx栓塞,5头用PHIL栓塞。栓塞后,进行传统CT、锥束CT和MRI检查。对伪影程度进行定性分级(五分制;用于CT和MRI)和定量分级(明确感兴趣区域(ROI)的HU值;仅用于CT)。

结果

无论是定性分析(如传统CT:中位数为2级对5级;p = 0.008)还是定量图像分析(如锥束CT:靠近栓塞剂铸型的ROI的标准差,中位数为94 HU对38 HU;p = 0.008),Onyx产生的伪影都明显更严重。在MRI中,Onyx和PHIL均未产生任何明显伪影。

结论

在实验性体内模型中,在传统CT和锥束CT方面,PHIL产生的伪影比Onyx少。